BioStock: Arcede proceeds to stability study in collaboration with Iconovo

Lund-based Arcede Pharma continues to advance its project with RCD405. The company recently concluded the toxicology program and can now announce that the collaboration on the formulation work with Iconovo is progressing with good results. The formulation work has been completed and the next step will be to conduct a technical stability study and then take the drug candidate into the clinic.

Read the full article at biostock.se:

https://www.biostock.se/en/2023/11/arcede-proceeds-to-stability-study-in-collaboration-with-iconovo/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se